Translabyrinthine vestibular neurectomy and simultaneous cochlear implant for Ménière’s disease

  • 384 Accesses

  • 1 Citations



Surgical management of Ménière’s disease (MD) is recommended in case of medical and intratympanic treatment failures. Translabyrinthine vestibular nerve section has been considered the gold standard for denervation procedures in order to control vertigo attacks, although at the cost of sacrificing residual hearing. To the best of our knowledge, no work has been published with regard to a group of patients submitted to translabyrinthine vestibular neurectomy and simultaneous cochlear implant for MD. The aim of the present study was to assess the effectiveness of translabyrinthine vestibular nerve section and simultaneous cochlear implant in a prospective study.


All adult patients (over 18 years of age) with a diagnosis of intractable unilateral definite MD and useless residual hearing function were enrolled after medical and intratympanic treatment failures. Pre- and postoperative otoneurological evaluation concerned: frequency of vertigo attacks, head impulse test and caloric testing, pure tone average and speech perception audiometry in quiet conditions, tinnitus handicap inventory test, functional level scale and rate of vertigo control, dizziness handicap inventory test, and MD patient-oriented severity index. At least 6 months of follow-up were needed to be enrolled in the study.


Four patients were included in the study. Translabyrinthine vestibular nerve section and simultaneous cochlear implant seemed to considerably improve the disabling effects of MD, achieving a good control of vestibular symptoms (mean pre/postoperative vertigo attacks per month: 16.5/0), resolving hearing loss (mean pre/postoperative pure tone average in the affected ear: 86.2/32.5 dB), improving the tinnitus (mean pre/postoperative tinnitus handicap inventory test: 77.2/6), and finally increasing the overall quality-of-life parameters.


In our preliminary report, translabyrinthine vestibular nerve section and simultaneous cochlear implant showed encouraging results in order to definitively control both vestibular and cochlear symptoms during the same therapeutic procedure.

This is a preview of subscription content, log in to check access.

Access options

Buy single article

Instant unlimited access to the full article PDF.

US$ 39.95

Price includes VAT for USA

Subscribe to journal

Immediate online access to all issues from 2019. Subscription will auto renew annually.

US$ 199

This is the net price. Taxes to be calculated in checkout.


  1. 1.

    Aksoy S, Firat Y, Alpar R (2007) The Tinnitus Handicap Inventory: a study of validity and reliability. Int Tinnitus J 13:94–98

  2. 2.

    Albera R, Canale A, Parandero F, Ducati A, Lanotte M (2011) Surgical indication in Ménière’s disease therapy: clinical and epidemiological aspects. Eur Arch Otorhinolaryngol 268:967–972

  3. 3.

    Basura GJ, Lin GC, Telian SA (2014) Comparison of second-echelon treatments for Ménière’s disease. JAMA Otolaryngol Head Neck Surg 140:754–761

  4. 4.

    Berryhill W, Graham M (2002) Chemical and physical labyrinthectomy for Ménière’s disease. Otolaryngol Clin N Am 35:675–682

  5. 5.

    Brandt T, Strupp M, Dieterich M (2016) Vestibular paroxysmia: a treatable neurovascular cross-compression syndrome. J Neurol 263:90–96

  6. 6.

    Bretlau P, Thomsen J, Tos M, Johnsen NJ (1989) Placebo effect in surgery for Ménière’s disease: nine-year follow-up. Am J Otol 10:259–261

  7. 7.

    Brookes G (1997) The role of vestibular nerve section in Ménière’s disease. Ear Nose Throat J 76:652–656, 658–659, 663

  8. 8.

    Casani AP, Cerchiai N, Navari E, Dallan I, Piaggi P, Sellari-Franceschini S (2014) Intratympanic gentamicin for Ménière’s disease: short- and long-term follow-up of two regimens of treatment. Otolaryngol Head Neck Surg 150:847–852

  9. 9.

    Casani AP, Piaggi P, Cerchiai N, Seccia V, Sellari-Franceschini S, Dallan I (2012) Intratympanic treatment of intractable unilateral Ménière disease: gentamicin or dexamethasone? A randomized controlled trial. Otolaryngol Head Neck Surg 146:430–437

  10. 10.

    Committee on Hearing and Equilibrium (1995) Committee on hearing and equilibrium guidelines for the diagnosis and evaluation of therapy in Ménière’s disease. American Academy of Otolaryngology-Head and Neck Foundation, Inc. Otolaryngol Head Neck Surg 113:181–185

  11. 11.

    Dandy W (1928) Ménière’s disease: its diagnosis and a method of treatment. Arch Surg 16:1127–1152

  12. 12.

    Dandy W (1941) The surgical treatment of Ménière’s disease. Surg Gynecol Obstet 72:421–425

  13. 13.

    De la Cruz A, Teufert KB, Berliner KI (2007) Transmastoid labyrinthectomy versus translabyrinthine vestibular nerve section: does cutting the vestibular nerve make a difference in outcome? Otol Neurotol 28:801–808

  14. 14.

    Deveze A, Bernard-Demanze L, Xavier F, Lavieille J-P, Elziere M (2014) Vestibular compensation and vestibular rehabilitation. Current concepts and new trends. Neurophysiol Clin 44:49–57

  15. 15.

    Duracinsky M, Mosnier I, Bouccara D, Sterkers O, Chassany O (2007) Literature review of questionnaires assessing vertigo and dizziness, and their impact on patients’ quality of life. Value Health 10:273–284

  16. 16.

    Eddington DK, Dobelle WH, Brackmann DE, Mladejovsky MG, Parkin JL (1978) Auditory prostheses research with multiple channel intracochlear stimulation in man. Ann Otol Rhinol Laryngol 87:1–39

  17. 17.

    Fisch U (1996) Transtemporal supralabyrinthine (middle cranial fossa) vestibular neurectomy: a review of the last 100 cases. Skull Base Surg 6:221–225

  18. 18.

    Fujita N, Nario K, Yamanaka T, Ueda T, Matsunaga T (1998) Neurovascular compression syndrome with Ménière’s disease—a report of the treatment of a patient with microvascular decompression. Auris Nasus Larynx 25:203–207

  19. 19.

    Furukawa M, Kitahara T, Horii A, Uno A, Imai T, Ohta Y, Morihana T, Inohara H, Mishiro Y, Sakagami M (2013) Psychological condition in patients with intractable Ménière’s disease. Acta Otolaryngol 133:584–589

  20. 20.

    Gates G, Verrall A (2005) Validation of the Ménière’s disease patient-oriented symptom-severity index. Arch Otolaryngol Head Neck Surg 131:863–867

  21. 21.

    Gates GA (2000) Clinimetrics of Ménière’s disease. Laryngoscope 110:8–11

  22. 22.

    Ghossaini S, Wazen J (2006) An update on the surgical treatment of Ménière’s diseases. J Am Acad Audiol 17:38–44

  23. 23.

    Glasscock M, Nashville T (1973) Vestibular nerve section. Middle fossa and translabyrinthine. Arch Otolaryngol 97:112–114

  24. 24.

    Glasscock ME, Hughes GB, Davis WE, Jackson CG (1984) Labyrinthectomy versus middle fossa vestibular nerve section in Ménière’s disease. A critical evaluation of relief of vertigo. Ann Otol Rhinol Laryngol 89:318–324

  25. 25.

    Glasscock ME, Jackson CG, Poe DS, Johnson GD (1989) What I think of sac surgery in 1989. Am J Otol 10:230–233

  26. 26.

    Hansen MR, Gantz BJ, Dunn C (2013) Outcomes after cochlear implantation for patients with single-sided deafness, including those with recalcitrant Ménière’s disease. Otol Neurotol 34:1681–1687

  27. 27.

    Holden LK, Neely JG, Gotter BD, Mispagel KM, Firszt JB (2012) Sequential bilateral cochlear implantation in a patient with bilateral Ménière’s disease. J Am Acad Audiol 23:256–268

  28. 28.

    Huang TS (1987) Valve implants compared to other surgical methods. Am J Otol 8:301–306

  29. 29.

    Huang TS (1999) Three new surgeries for treatment of intractable Ménière’s disease. Am J Otol 20:233–237

  30. 30.

    Jacobson G, Newman CW (1990) The development of the Dizziness Handicap Inventory. Arch Otolaryngol Head Neck Surg 116:424–427

  31. 31.

    Jennings R, Reams C, Jacobson J, Cole J (1989) Results of surgical treatment for Ménière’s disease. Otolaryngol Head Neck Surg 100:195–199

  32. 32.

    Jung TT, Anderson JH, Paparella MM (1987) Cochleovestibular nerve sections in labyrinthectomized patients. Am J Otol 8:155–158

  33. 33.

    Kaylie DM, Jackson CG, Gardner EK (2005) Surgical management of Ménière’s disease in the era of gentamicin. Otolaryngol Head Neck Surg 132:443–450

  34. 34.

    Kveton JF (2006) Revision surgery for vertigo. Otolaryngol Clin N Am 39:741–750

  35. 35.

    Langman AW, Lindeman RC (1993) Surgery for vertigo in the nonserviceable hearing ear: transmastoid labyrinthectomy or translabyrinthine vestibular nerve section. Laryngoscope 103:1321–1325

  36. 36.

    Lassaletta L, Aristegui M, Medina M, Aranguez G, Pérez-Mora RM, Falcioni M, Gavilán J, Piazza P, Sanna M (2014) Ipsilateral cochlear implantation in patients with sporadic vestibular schwannoma in the only or best hearing ear and in patients with NF2. Eur Arch Otorhinolaryngol. doi:10.1007/s00405-014-3450-3

  37. 37.

    Levine SC (2002) Vestibular nerve section. Oper Tech Otolaryngol Head Neck Surg 12:137–140

  38. 38.

    Levine SC, Glasscock M, McKennan KX (1990) Long-term results of labyrinthectomy. Laryngoscope 100:125–127

  39. 39.

    Linthicum FH, Alonso A, Denia A (1979) Traumatic neuroma: a complication of transcanal labyrinthectomy. Arch Otolaryngol 105:654–655

  40. 40.

    Lloyd SK, Glynn FJ, Rutherford SA, King AT, Mawman DJ, O’Driscoll MP, Evans DG, Ramsden RT, Freeman SR (2014) Ipsilateral cochlear implantation after cochlear nerve preserving vestibular schwannoma surgery in patients with neurofibromatosis type 2. Otol Neurotol 35:43–51

  41. 41.

    Lopez-Escamez JA, Carey J, Chung WH, Goebel JA, Magnusson M, Mandalà M, Newman-Toker DE, Strupp M, Suzuki M, Trabalzini F, Bisdorff A, Classification Committee of the Barany Society, Japan Society for Equilibrium Research, European Academy of Otology and Neurotology (EAONO), Equilibrium Committee of the American Academy of Otolaryngology-Head and Neck Surgery (AAO-HNS), Korean Balance Society (2015) Diagnostic criteria for Ménière’s disease. J Vestib Res 25:1–7

  42. 42.

    Lustig LR, Yeagle J, Niparko JK, Minor LB (2003) Cochlear implantation in patients with bilateral Ménière’s syndrome. Otol Neurotol 24:397–403

  43. 43.

    MacKeith SAC, Bottrill ID, Ramsden JD (2014) Simultaneous labyrinthectomy with cochlear implantation in patients with bilateral Ménière’s disease. Ann Otol Rhinol Laryngol 123:485–489

  44. 44.

    Mancini F, Catalani M, Carru M, Monti B (2002) History of Ménière’s disease and its clinical presentation. Otolaryngol Clin N Am 35:565–580

  45. 45.

    Mick P, Amoodi H, Arnoldner C, Shipp D, Friesen L, Lin V, Nedzelski J, Chen J (2014) Cochlear implantation in patients with advanced Ménière’s disease. Otol Neurotol 35:1172–1178

  46. 46.

    Møller AR, Møller MB (2007) Microvascular decompression operations. Prog Brain Res 166:397–400

  47. 47.

    Møller MB, Møller AR, Jannetta PJ, Jho HD, Sekhar LN (1993) Microvascular decompression of the eighth nerve in patients with disabling positional vertigo: selection criteria and operative results in 207 patients. Acta Neurochir (Wien) 125:75–82

  48. 48.

    Monsell EM, Brackmann DE, Linthicum FH (1988) Why do vestibular destructive procedures sometimes fail? Otolaryngol Head Neck Surg 99:472–479

  49. 49.

    Monzani D, Genovese E, Marrara A, Gherpelli C, Pingani L, Forghieri M, Rigatelli M, Guadagnin T, Arslan E (2008) Validity of the Italian adaptation of the Tinnitus Handicap Inventory; focus on quality of life and psychological distress in tinnitus sufferers. Acta Otorhinolaryngol Ital 28:126–134

  50. 50.

    Murphy M, Gates G (1999) Measuring the effects of Ménière’s disease: results of the Patient-Oriented Severity Index (MD POSI) version 1. Ann Otol Rhinol Laryngol 108:331–337

  51. 51.

    Nelson R (2001) Translabyrinthine vestibular neurectomy. In: Brackmann DE, Shelton C, Arriaga MA (eds) Otologic surgery, 2nd edn. WB Saunders, Philadelphia, pp 433–439

  52. 52.

    Newman CW, Jacobson GP, Spitzer JB (1996) Development of the Tinnitus Handicap Inventory. Arch Otolaryngol Head Neck Surg 122:143–148

  53. 53.

    Norré M, Forrez G, Beckers A (1987) Vestibular dysfunction causing instability in aged patients. Acta Otolaryngol 104:50–55

  54. 54.

    Ozdoğmuş O, Sezen O, Kubilay U, Saka E, Duman U, San T, Cavdar S (2004) Connections between the facial, vestibular and cochlear nerve bundles within the internal auditory canal. J Anat 205:65–75

  55. 55.

    Paparella MM, Fina M (2002) Endolymphatic sac enhancement: reversal of pathogenesis. Otolaryngol Clin N Am 35:621–637

  56. 56.

    Pappas DG (1997) Vestibular nerve section: long term follow-up. Laryngoscope 107:1203–1209

  57. 57.

    Portmann G (1927) The saccus endolymphaticus and an operation for draining for the relief of vertigo. R Soc Med 20:1862–1867

  58. 58.

    Pullens B, Verschuur HP, Van Benthem PP (2013) Surgery for Ménière’s disease. Cochrane Database Syst Rev 2:1–19

  59. 59.

    Quaglieri S, Gatti O, Rebecchi E, Manfrin M, Tinelli C, Mira E, Benazzo M (2014) Intratympanic gentamicin treatment “as needed” for Ménière’s disease. Long-term analysis using the Kaplan–Meier method. Eur Arch Otorhinolaryngol 271:1443–1449

  60. 60.

    Rauch S (2010) Clinical hints and precipitating factors in patients suffering from Ménière’s disease. Otolaryngol Clin N Am 43:1011–1017

  61. 61.

    Reid CB, Eisenberg R, Halmagyi GM, Fagan PA (1996) The outcome of vestibular nerve section for intractable vertigo: the patient’s point of view. Laryngoscope 106:1553–1556

  62. 62.

    Sajjadi H, Paparella MM (2008) Ménière’s disease. Lancet 372:406–414

  63. 63.

    Schuknecht H (1956) Ablation therapy for the relief of Ménière’s disease. Laryngoscope 66:859–870

  64. 64.

    Semaan MT, Megerian CA (2011) Ménière’s disease: a challenging and relentless disorder. Otolaryngol Clin N Am 44:383–403

  65. 65.

    Semaan MT, Zheng QY, Han F, Zheng Y, Yu H, Heaphy JC, Megerian CA (2013) Characterization of neuronal cell death in the spiral ganglia of a mouse model of endolymphatic hydrops. Otol Neurotol 34:559–569

  66. 66.

    Silverstein H, Jackson LE (2002) Vestibular nerve section. Otolaryngol Clin N Am 35:655–673

  67. 67.

    Silverstein H, Norrell H, Smouha E, Jones R, Rosenberg S (1990) An evolution of approach in vestibular neurectomy. Otolaryngol Head Neck Surg 102:374–381

  68. 68.

    Silverstein H, Smouha E, Jones R (1989) Natural history vs. surgery for Ménière’s disease. Otolaryngol Head Neck Surg 100:6–16

  69. 69.

    Sood AJ, Lambert PR, Nguyen SA, Meyer TA (2014) Endolymphatic sac surgery for Ménière’s disease: a systematic review and meta-analysis. Otol Neurotol 35:1033–1045

  70. 70.

    Stokroos R, Kingma H (2004) Selective vestibular ablation by intratympanic gentamicin in patients with unilateral active Ménière’s disease: a prospective, double-blind, placebo- controlled, randomized clinical trial. Acta Otolaryngol 124:172–175

  71. 71.

    Teufert KB, Berliner KI, De la Cruz A (2007) Persistent dizziness after surgical treatment of vertigo: an exploratory study of prognostic factors. Otol Neurotol 28:1056–1062

  72. 72.

    Teufert KB, Doherty J (2010) Endolymphatic sac shunt, labyrinthectomy, and vestibular nerve section in Ménière’s disease. Otolaryngol Clin N Am 43:1091–1111

  73. 73.

    Thomsen J, Bonding P, Becker B, Stage J, Tos M (1998) The non-specific effect of endolymphatic sac surgery in treatment of Ménière’s disease: a prospective, randomized controlled study comparing “classic” endolymphatic sac surgery with the insertion of a ventilating tube in the tympanic membrane. Acta Otolaryngol 118:769–773

  74. 74.

    Thomsen J, Bretlau P, Tos M, Johnsen NJ (1981) Placebo effect in surgery for Ménière’s disease. A double-blind, placebo-controlled study on endolymphatic sac shunt surgery. Arch Otolaryngol 107:271–277

  75. 75.

    Van de Heyning P, Vermeire K, Diebl M, Nopp P, Anderson I, De Ridder D (2008) Incapacitating unilateral tinnitus in single-sided deafness treated by cochlear implantation. Ann Otol Rhinol Laryngol 117:645–652

  76. 76.

    Vermeire K, Van Yper L, De Vel E, Dhooge I (2014) Is cochlear implantation an effective treatment for Ménière’s disease? B-ENT 10:93–98

  77. 77.

    Wareing M, O’Connor A (1997) The role of labyrinthectomy and cochlear implantation in Ménière’s disease. Ear Nose Throat J 76:664–672

  78. 78.

    Ylikoski J, Belal A (1981) Human vestibular nerve morphology and labyrinthectomy. Am J Otolaryngol 2:81–93

Download references

Author information

Correspondence to Pietro Canzi.

Ethics declarations

Conflict of interest


Informed consent

Informed consent was obtained from all individual participants included in the study.

Ethical approval

All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and national research committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards.

This article does not contain any studies with animals performed by any of the authors.

Electronic supplementary material

Below is the link to the electronic supplementary material.

Translabyrinthine vestibular neurectomy and simultaneous cochlear implant (MP4 153997 kb)

Translabyrinthine vestibular neurectomy and simultaneous cochlear implant (MP4 153997 kb)

Rights and permissions

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Canzi, P., Manfrin, M., Perotti, M. et al. Translabyrinthine vestibular neurectomy and simultaneous cochlear implant for Ménière’s disease. Acta Neurochir 159, 123–130 (2017) doi:10.1007/s00701-016-2996-9

Download citation


  • Cochlear implant
  • Translabyrinthine neurectomy
  • Nerve section
  • Ménière’s disease